Cochrane in context: Probiotics for prevention of necrotizing enterocolitis in preterm infants

Evidence-Based Child Health

Volumn 9, Issue 3, 2014, Pages 672-674

  Robinson, Joan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Necrotizing enterocolitis; Preterm infants; Probiotics; Prophylaxis

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

BIFIDOBACTERIUM; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG SAFETY; ENTERAL DRUG ADMINISTRATION; EXTREMELY LOW BIRTH WEIGHT; HIGH RISK POPULATION; HUMAN; INFANT MORTALITY; INFECTION RISK; LACTOBACILLUS; NECROTIZING ENTEROCOLITIS; NOTE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; CROSS INFECTION; ENTEROCOLITIS, NECROTIZING; INFUSION; MORTALITY; NEWBORN; PRACTICE GUIDELINE;

CROSS INFECTION; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, PARENTERAL; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; SEPSIS;

EID: 84927509691     PISSN: 20404050     EISSN: 15576272     Source Type: Journal    
DOI: 10.1002/ebch.1977     Document Type: Note

References (9)

1. Jenke A, Ruf EM, Hoppe T, Heldmann M, Wirth S. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed 2012;97:F217-F218.
2. Millar M, Wilks M, Fleming P, Costeloe K. Should the use of probiotics in the preterm be routine? Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F70-F74. DOI: 10.1136/adc.2009.178939. [Epub 24 September 2010].
3. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, Morley CJ, Garland SM; ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055-1062. DOI: 10.1542/peds.2013-1339.[Epub 18 November 2013].
4. Beattie LM, Hansen R, Barclay AR. Probiotics for preterm infants: confounding features warrant caution. Pediatrics. 2010; 126(3):e742-e743; author reply e743-5. DOI: 10.1542/peds.2010-1949C.
5. Janvier A, Lantos J, Barrington K. The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research. Acta Paediatr. 2013;102(2):116-118. DOI: 10.1111/apa.12083. [Epub 15 December 2012].
6. Mihatsch WA, Braegger CP, Desci T, Kolacek S, Lanzinger H, Mayer B, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr. 2012;31:6-15.
7. Bernardo WM, Aires FT, Carneiro RM, de Sac FP, Rullo VEV, Burns DA. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J Pediatr (Rio J). 2013;89:18-24.
8. Marchand V; Canadian Paediatric Society NaGC. Using probiotics in the paediatric population Paediatr Child Health. 2012;17(10):575. [Epub 3 December 2012].
9. Thomas DW, Greer FR, American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition Probiotics and prebiotics in pediatrics. Pediatrics 2010;126(6):1217-1231.